SLC10A1 (solute carrier family 10 member 1)

2007-02-01  

Identity

HGNC
LOCATION
14q24.1
LOCUSID
ALIAS
FHCA2,NTCP
FUSION GENES

Other Information

Locus ID:

NCBI: 6554
MIM: 182396
HGNC: 10905
Ensembl: ENSG00000100652

Variants:

dbSNP: 6554
ClinVar: 6554
TCGA: ENSG00000100652
COSMIC: SLC10A1

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000100652ENST00000216540Q14973

Expression (GTEx)

0
10
20
30
40
50
60
70
80
90
100

Pathways

PathwaySourceExternal ID
Bile secretionKEGGko04976
Bile secretionKEGGhsa04976
MetabolismREACTOMER-HSA-1430728
Metabolism of lipids and lipoproteinsREACTOMER-HSA-556833
Bile acid and bile salt metabolismREACTOMER-HSA-194068
Recycling of bile acids and saltsREACTOMER-HSA-159418

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
380490092024Role of sodium taurocholate cotransporting polypeptide (NTCP) in HBV-induced hepatitis: Opportunities for developing novel therapeutics.0
382583062024Association between NTCP hepatic expression and inflammation/fibrosis as well as gender-specific differences in chronic HBV-infected patients.0
385444092024Molecular mechanisms of Na(+)-driven bile acid transport in human NTCP.1
388696222024SLC10A1 rs2296651 variant (S267F mutation) predicts biochemical traits, hepatitis B virus infection susceptibility and the risk of gallstone disease.0
380490092024Role of sodium taurocholate cotransporting polypeptide (NTCP) in HBV-induced hepatitis: Opportunities for developing novel therapeutics.0
382583062024Association between NTCP hepatic expression and inflammation/fibrosis as well as gender-specific differences in chronic HBV-infected patients.0
385444092024Molecular mechanisms of Na(+)-driven bile acid transport in human NTCP.1
388696222024SLC10A1 rs2296651 variant (S267F mutation) predicts biochemical traits, hepatitis B virus infection susceptibility and the risk of gallstone disease.0
371032242023Interactions of Na(+)/taurocholate cotransporting polypeptide with host cellular proteins upon hepatitis B and D virus infection: novel potential targets for antiviral therapy.3
372342372023LINC00659 Inhibits Hepatocellular Carcinoma Malignant Progression by Blocking Aerobic Glycolysis through FUS Recruitment and SLC10A1 Modulation.3
377287072023Aborted infection of human sodium taurocholate cotransporting polypeptide (hNTCP) expressing woodchuck hepatocytes with hepatitis B virus (HBV).0
371032242023Interactions of Na(+)/taurocholate cotransporting polypeptide with host cellular proteins upon hepatitis B and D virus infection: novel potential targets for antiviral therapy.3
372342372023LINC00659 Inhibits Hepatocellular Carcinoma Malignant Progression by Blocking Aerobic Glycolysis through FUS Recruitment and SLC10A1 Modulation.3
377287072023Aborted infection of human sodium taurocholate cotransporting polypeptide (hNTCP) expressing woodchuck hepatocytes with hepatitis B virus (HBV).0
342669682022Sodium(+)/taurocholate cotransporting polypeptide as target therapy for liver fibrosis.15

Citation

Dessen P

SLC10A1 (solute carrier family 10 member 1)

Atlas Genet Cytogenet Oncol Haematol. 2007-02-01

Online version: http://atlasgeneticsoncology.org/gene/46316/case-report-explorer/css/template-nav.css